Nevro Corp
(NYSE:NVRO)
$
4.58
0.26 (6.02%)
Market Cap: 171.62 Mil
Enterprise Value: 141.17 Mil
PE Ratio: 0
PB Ratio: 0.63
GF Score: 43/100 Nevro Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021 / 03:45PM GMT
Release Date Price:
$121.17
(+1.77%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
Good morning, and thank you for joining us for the third day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley. It's my pleasure to have Nevro Chairman, President and CEO, Keith Grossman; and CFO, Rod MacLeod, with us today.
And really quickly, before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to a Morgan Stanley sales representative.
With that, Keith, Rod, thank you both for joining us today.
D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President
Thanks, Cecilia.
Roderick H. MacLeod
Nevro Corp. - CFO
Thanks.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot